Samsung Bioepis Launches Ustekinumab Biosimilar, Marking Its First Product Launch in Japan
资讯
2026-05-21
Ustekinumab BS 45 mg Syringe for S.C. Injection「NIPRO」 is now available in Japan, after its listing under the National Health Insurance (NHI) Drug Price Standard
Marks first launch in Japan through ...